MXPA03007391A - Enlazantes polimericos ramificados terminalmente y conjugados polimericos que contienen los mismos. - Google Patents
Enlazantes polimericos ramificados terminalmente y conjugados polimericos que contienen los mismos.Info
- Publication number
- MXPA03007391A MXPA03007391A MXPA03007391A MXPA03007391A MXPA03007391A MX PA03007391 A MXPA03007391 A MX PA03007391A MX PA03007391 A MXPA03007391 A MX PA03007391A MX PA03007391 A MXPA03007391 A MX PA03007391A MX PA03007391 A MXPA03007391 A MX PA03007391A
- Authority
- MX
- Mexico
- Prior art keywords
- polymeric
- terminally
- same
- branched
- linkers
- Prior art date
Links
- 229940002612 prodrug Drugs 0.000 abstract 3
- 239000000651 prodrug Substances 0.000 abstract 3
- 241000124008 Mammalia Species 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000003379 elimination reaction Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/65—Peptidic linkers, binders or spacers, e.g. peptidic enzyme-labile linkers
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US27251101P | 2001-02-20 | 2001-02-20 | |
PCT/US2002/004780 WO2002066066A1 (en) | 2001-02-20 | 2002-02-19 | Terminally-branched polymeric linkers and polymeric conjugates containing the same |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA03007391A true MXPA03007391A (es) | 2003-12-04 |
Family
ID=23040108
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA03007391A MXPA03007391A (es) | 2001-02-20 | 2002-02-19 | Enlazantes polimericos ramificados terminalmente y conjugados polimericos que contienen los mismos. |
Country Status (9)
Country | Link |
---|---|
US (1) | US20020161052A1 (es) |
EP (1) | EP1361895B1 (es) |
JP (1) | JP2004530736A (es) |
AT (1) | ATE378071T1 (es) |
CA (1) | CA2437986A1 (es) |
DE (1) | DE60223496T2 (es) |
DK (1) | DK1361895T3 (es) |
MX (1) | MXPA03007391A (es) |
WO (1) | WO2002066066A1 (es) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6624142B2 (en) * | 1997-12-30 | 2003-09-23 | Enzon, Inc. | Trimethyl lock based tetrapartate prodrugs |
US7332164B2 (en) * | 2003-03-21 | 2008-02-19 | Enzon Pharmaceuticals, Inc. | Heterobifunctional polymeric bioconjugates |
EP1533385A1 (en) * | 2003-09-05 | 2005-05-25 | Nuevolution A/S | Templated compounds for generation of encoded molecules and directional methods using such compounds |
CN101023119B (zh) | 2004-09-22 | 2010-05-05 | 日本化药株式会社 | 新型嵌段共聚物,胶束制剂以及含胶束制剂为活性组分的抗癌剂 |
PT2279758E (pt) | 2005-06-16 | 2015-05-27 | Nektar Therapeutics | Conjugados possuindo uma ligação degradável e reagentes poliméricos úteis na preparação de tais conjugados |
KR20080106254A (ko) | 2006-03-28 | 2008-12-04 | 니폰 가야꾸 가부시끼가이샤 | 탁산류의 고분자 결합체 |
WO2007135910A1 (ja) | 2006-05-18 | 2007-11-29 | Nippon Kayaku Kabushiki Kaisha | ポドフィロトキシン類の高分子結合体 |
AU2007274402A1 (en) * | 2006-07-19 | 2008-01-24 | Nippon Kayaku Kabushiki Kaisha | Polymer conjugate of combretastatin |
WO2008056596A1 (en) | 2006-11-06 | 2008-05-15 | Nippon Kayaku Kabushiki Kaisha | Polymeric derivative of nucleic acid metabolic antagonist |
EP2090607B1 (en) | 2006-11-08 | 2015-05-20 | Nippon Kayaku Kabushiki Kaisha | Polymeric derivative of nucleic acid metabolic antagonist |
WO2009041570A1 (ja) | 2007-09-28 | 2009-04-02 | Nippon Kayaku Kabushiki Kaisha | ステロイド類の高分子結合体 |
CN101977631A (zh) | 2008-03-18 | 2011-02-16 | 日本化药株式会社 | 生理活性物质的高分子量偶联物 |
WO2009136572A1 (ja) | 2008-05-08 | 2009-11-12 | 日本化薬株式会社 | 葉酸若しくは葉酸誘導体の高分子結合体 |
US8808749B2 (en) | 2009-05-15 | 2014-08-19 | Nippon Kayaku Kabushiki Kaisha | Polymer conjugate of bioactive substance having hydroxy group |
EP2641605B1 (en) | 2010-11-17 | 2018-03-07 | Nippon Kayaku Kabushiki Kaisha | Polymer derivative of cytidine metabolism antagonist |
RU2623426C2 (ru) | 2011-09-11 | 2017-06-26 | Ниппон Каяку Кабусики Кайся | Способ получения блок-сополимера |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5552391A (en) * | 1990-01-16 | 1996-09-03 | La Jolla Pharmaceutical Company | Chemically-defined non-polymeric valency platform molecules and conjugates thereof |
AU4406793A (en) * | 1992-06-04 | 1993-12-30 | Clover Consolidated, Limited | Water-soluble polymeric carriers for drug delivery |
US5880131A (en) * | 1993-10-20 | 1999-03-09 | Enzon, Inc. | High molecular weight polymer-based prodrugs |
US5840900A (en) * | 1993-10-20 | 1998-11-24 | Enzon, Inc. | High molecular weight polymer-based prodrugs |
US5965566A (en) * | 1993-10-20 | 1999-10-12 | Enzon, Inc. | High molecular weight polymer-based prodrugs |
US6011042A (en) * | 1997-10-10 | 2000-01-04 | Enzon, Inc. | Acyl polymeric derivatives of aromatic hydroxyl-containing compounds |
US6180095B1 (en) * | 1997-12-17 | 2001-01-30 | Enzon, Inc. | Polymeric prodrugs of amino- and hydroxyl-containing bioactive agents |
US5965119A (en) * | 1997-12-30 | 1999-10-12 | Enzon, Inc. | Trialkyl-lock-facilitated polymeric prodrugs of amino-containing bioactive agents |
US6153655A (en) * | 1998-04-17 | 2000-11-28 | Enzon, Inc. | Terminally-branched polymeric linkers and polymeric conjugates containing the same |
-
2002
- 2002-02-19 JP JP2002565624A patent/JP2004530736A/ja active Pending
- 2002-02-19 MX MXPA03007391A patent/MXPA03007391A/es active IP Right Grant
- 2002-02-19 US US10/078,649 patent/US20020161052A1/en not_active Abandoned
- 2002-02-19 AT AT02709573T patent/ATE378071T1/de not_active IP Right Cessation
- 2002-02-19 WO PCT/US2002/004780 patent/WO2002066066A1/en active IP Right Grant
- 2002-02-19 DE DE60223496T patent/DE60223496T2/de not_active Expired - Lifetime
- 2002-02-19 DK DK02709573T patent/DK1361895T3/da active
- 2002-02-19 EP EP02709573A patent/EP1361895B1/en not_active Expired - Lifetime
- 2002-02-19 CA CA002437986A patent/CA2437986A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20020161052A1 (en) | 2002-10-31 |
CA2437986A1 (en) | 2002-08-29 |
JP2004530736A (ja) | 2004-10-07 |
WO2002066066A1 (en) | 2002-08-29 |
WO2002066066A9 (en) | 2003-10-16 |
EP1361895A1 (en) | 2003-11-19 |
EP1361895B1 (en) | 2007-11-14 |
DE60223496D1 (de) | 2007-12-27 |
DK1361895T3 (da) | 2008-02-18 |
EP1361895A4 (en) | 2005-01-19 |
ATE378071T1 (de) | 2007-11-15 |
DE60223496T2 (de) | 2008-10-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA03007392A (es) | Enlazantes polimericos ramificados terminalmente y conjugados polimericos que contienen los mismos. | |
MXPA03007391A (es) | Enlazantes polimericos ramificados terminalmente y conjugados polimericos que contienen los mismos. | |
CZ2019248A3 (cs) | 40-O-(2-hydroxyethyl)rapamycin pro použití jako jediná účinná látka při léčení solidního nádoru | |
NO20013451L (no) | 1-Heterocyklus-substituerte diarylaminer | |
DK1093819T3 (da) | Forbindelse og præparat til tilförsel af aktive midler | |
WO2000040203A3 (en) | Polymeric delivery agents and delivery agent compounds | |
PL356904A1 (en) | Pharmaceutical compositions | |
AU5250300A (en) | Gas-generating agent composition for pretentioner | |
EP1181323A4 (en) | BIOMATERIALS ADDED BY NUCLEOPHILIC REACTION TO CONJUGATED UNSATURATED GROUPS | |
TW200806333A (en) | Single phase whitening dentifrice | |
ATE200030T1 (de) | Pegylationsverfahren | |
MXPA02002898A (es) | Pirazolopirimidinas como agentes terapeuticos. | |
IL131651A0 (en) | A pharmaceutical formulation containing benzimidazoles with amino acid/caclodextrin combinations and a process for producing the same | |
TR200101103T2 (tr) | CGMP PDE-İnhibitörü içeren kontrollu serbest bırakılan farmasötik formülasyonlar | |
GR990100140A (el) | Νεες ενωσεις | |
DE10084671T1 (de) | Pharmazeutische Zusammensetzungen | |
ATE297904T1 (de) | Halo-alkoxycarbonylverbindungen | |
DE69907926D1 (de) | 1,2,4-triazol-3-thion verbindungen | |
IL157540A0 (en) | N-(aryl)-2-arylethenesulphonamides and therapeutic uses thereof | |
DK1666924T3 (da) | Kovalent bundne, hydrofile belægningssammensætninger til implantater | |
MXPA02005045A (es) | Preparaciones farmaceuticas que contiene agentes citostaticos y aceptores de electrones para el tratamiento de cancer. | |
WO1998033470A3 (en) | Substituted perylenequinones for use in photodynamic therapy | |
EP1160799A4 (en) | REACTION DEVICE FOR ELECTRON BEAM PROJECTION SYSTEM | |
HK1050533A1 (en) | Substituted pyrroles as antiproliferative agents for the treatment of cancer. | |
WO2001032216A3 (fr) | Produit comprenant au moins une substance inhibitrice des no synthases en association avec au moins une substance inhibitrice des phospholipases a2 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |